Evidence map›Paper›PMID 42007198›Full record

ArticleCJC open2026

Changes in the Heart Sounds Between Discharge and Initial Follow-Up and Subsequent Cardiac Events in Patients with Acute Decompensated Heart Failure.

Jun Shitara, Nobutaka Murata, Shoichiro Yatsu, Azusa Murata, Hiroki Matsumoto, Takao Kato, Shoko Suda, Ryo Naito, Masaru Hiki, Hiroyuki Daida and 1 more

Abstract read
In one paragraph

Article in CJC open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Jun ShitaraDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Nobutaka MurataCorporate R&D, Asahi Kasei Corporation, Tokyo, Japan.
Shoichiro YatsuDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Azusa MurataDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hiroki MatsumotoDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Takao KatoDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Shoko SudaDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Ryo NaitoDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Masaru HikiDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Hiroyuki DaidaDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Takatoshi KasaiDepartment of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Cardiac acoustic biomarkers (CABs) measured by acoustic cardiography support the diagnosis or monitoring of worsening heart failure (HF). Our previous observational study suggested that temporal changes in CABs in patients with acute decompensated HF may reflect changes in cardiac function during hospitalization and between discharge and the first follow-up visit. This study aimed to assess whether changes in CABs between discharge and the first follow-up visit in such patients are associated with cardiac events over a 1-year follow-up period. Methods: This study was a follow-up to our previous observational study. CABs assessed at discharge and the first clinic visit following discharge were examined. The incidence of cardiac events, defined as the composite of death and rehospitalization due to worsening HF following the first clinic visit, was investigated. Results: Among 60 patients enrolled in our previous study, 47 who had CAB data at discharge and their first clinic visit were monitored for 1 year. During a median follow-up period of 351 days, 17 of these 47 patients experienced cardiac events, including 4 deaths and 13 rehospitalizations. The cumulative event-free survival rate was significantly poorer in patients whose change in third heart sound (ΔS3) strength was ≥ 0.1 than in those whose ΔS3 strength was < 0.1. Multivariate Cox regression models indicated that the ΔS3 strength increase was significantly associated with increased risk of cardiac events. Conclusions: An increase in S3 as assessed using the CAB device between discharge and the first clinic visit may be a predictor of subsequent cardiac events in patients initially hospitalized for acute decompensated HF.

Indexed as

acoustic cardiographycardiac acoustic biomarkersclinical outcomes

Identifiers

PMID42007198
PMCPMC13084283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.